Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

shutterstock_273326141

Nestlé to acquire remaining shares in Aimmune for $2.6 billion

September 2, 2020 Research and Development, Sales and Marketing Aimmune, acquisition, nestle, pharma

Food and drink giant Nestlé has confirmed it is in motion to scoop up the remaining shares in Californian biotech …
News
covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

September 2, 2020 Research and Development

The COVID-19 news round-up this week focuses on coronavirus treatments, with Celltrion Group announcing that the Korean Ministry of Food …
News
index_ph001

Daiichi Sankyo’s Nilemdo “significantly” reduces cholesterol levels at ESC 2020

September 1, 2020 Manufacturing and Production, Research and Development Daiichi Sankyo, Nilemdo, pharma

Daiichi Sankyo has unveiled promising new benefit for Nilemdo (bempedoic acid) at the ESC Congress 2020 over the weekend for …
News
covid_innovations_bamc_1

Genexine’s cytokine drug effective in treating coronavirus patients, new study suggests

August 27, 2020 Research and Development COVID-19

Genexine’s recent clinical trial investigating how its cytokine therapy treats coronavirus has proven effective, according to the company. 
News
flu_shot_2019_1

Moderna says its COVID-19 vaccine shows promise in elderly patients

August 27, 2020 Research and Development Moderna vaccine, Operation Warp Speed

Moderna has announced that its coronavirus vaccine candidate has shown promise in generating an immune response in elderly patients in …
News
fda_21

FDA approves Abbott’s rapid portable COVID-19 test

August 27, 2020 Research and Development Abbott, COVID-19, FDA, test

The FDA has given emergency clearance for Abbott’s portable COVID-19 test that it will sell for just $5.  The company’s …
News
800px-temazepam_10mg_tablets-1_1

Canada to roll out automated drug dispensers to help fight opioid crisis

August 27, 2020 Research and Development opioid, opioid crisis, opioids

Canada is set to roll out automated drug dispensers that can provide clean, doctor-prescribed medicine to opioid addicts by scanning …
News
800px-nhs_nnuh_entrance_2

Thousands of coronavirus cases recorded in hospital were caught on site, new research suggests

August 26, 2020 Research and Development coronavirus

Thousands of coronavirus cases are thought to have been transmitted within UK hospitals, according to a new study. Researchers at …
News
unnamed_1

US Department of Justice charges Teva with generic price fixing

August 26, 2020 Research and Development Department of Justice, Teva Pharmaceuticals

The US Department of Justice (DOJ) has charged Teva Pharmaceuticals with conspiracy to fix the price of its generic drugs. …
News

75-year-old Nottinghamshire woman may be first known British victim of coronavirus

August 26, 2020 Research and Development COVID-19, coronavirus

A 75-year-old woman from Nottinghamshire is thought to be the first British case and victim of COVID-19. She tested positive …
News
8330379372_1e55f3c4c2_b

Africa declared free of wild polio

August 26, 2020 Research and Development polio, vaccines

The Africa Regional Certification Commission has declared Africa to be free from wild polio. Nigeria, Pakistan and Afghanistan were the …
News
fifififif

Working Life Interview: Fiona Huzarski, Vice President of Global HR, ADVANZ PHARMA

August 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Working Life, feature

“Every company is different, so you have to be open-minded and receptive to the culture when joining.” Can you briefly …
Feature
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

August 26, 2020 Research and Development COVID, COVID-19, coronavirus

In COVID-19 news this week, China is set to move ahead with human testing of a potential coronavirus vaccine that …
News
gilead-sciences

FDA turns down Gilead’s JAK inhibitor filgotinib in rheumatoid arthritis, endangering 2020 approval hopes

August 20, 2020 Research and Development, Sales and Marketing FDA, Gilead, filgotinib

Gilead’s JAK inhibitor filgotinib has been unexpectedly knocked back by the FDA as a therapy to treat moderately to severely …
News
fda_21

FDA delays BioMarin’s gene therapy for haemophilia A

August 20, 2020 Research and Development, Sales and Marketing FDA

The FDA has delayed Roctavin, BioMarin’s gene therapy for haemophilia A, by a year to wait for more extensive results, …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025